1. Pharma marketing techniques might improve drug safety

   Comment 19 January 2013 Pages: 1 - 1

2. Hypersensitivity to Gardasil vaccine uncommon

   Clinical study 19 January 2013 Pages: 2 - 2

3. Autism linked to valproic acid exposure in utero

   Clinical study 19 January 2013 Pages: 2 - 2

4. Prenatal fluoxetine exposure may be associated with CV anomalies

   Clinical study 19 January 2013 Pages: 2 - 2

5. Tinzaparin ongoing safety review inconclusive, says FDA

   News item 19 January 2013 Pages: 3 - 3

6. Contaminated heparin: the CDC investigation

   News item 19 January 2013 Pages: 3 - 3

7. Acetic acid

   Case report 19 January 2013 Pages: 4 - 4

8. Acitretin

   Case report 19 January 2013 Pages: 4 - 4

9. Adalimumab

   Case report 19 January 2013 Pages: 4 - 4

10. Alefacept/methotrexate

    Case report 19 January 2013 Pages: 5 - 5

11. Amantadine

    Case report 19 January 2013 Pages: 5 - 5

12. Aminophylline

    Case report 19 January 2013 Pages: 5 - 5

13. Adalimumab/infliximab

    Case report 19 January 2013 Pages: 5 - 5

14. Amiodarone

    Case report 19 January 2013 Pages: 6 - 6

15. Antineoplastics

    Case report 19 January 2013 Pages: 6 - 6

16. Amiodarone

    Case report 19 January 2013 Pages: 6 - 6

17. Antineoplastics/iodixanol

    Case report 19 January 2013 Pages: 7 - 7

18. Antiretrovirals

    Case report 19 January 2013 Pages: 7 - 7

19. Aprepitant/ifosfamide interaction

    Case report 19 January 2013 Pages: 8 - 8

20. Antituberculars

    Case report 19 January 2013 Pages: 8 - 8

21. Antiretrovirals

    Case report 19 January 2013 Pages: 8 - 8

22. Azathioprine/mycophenolate sodium/prednisone

    Case report 19 January 2013 Pages: 9 - 9

23. Azathioprine

    Case report 19 January 2013 Pages: 9 - 9

24. Baclofen withdrawal

    Case report 19 January 2013 Pages: 9 - 10

25. Bupropion overdose

    Case report 19 January 2013 Pages: 10 - 10

26. Capecitabine

    Case report 19 January 2013 Pages: 10 - 10

27. Butyrolactone abuse

    Case report 19 January 2013 Pages: 10 - 10

28. Bicalutamide/leuprorelin

    Case report 19 January 2013 Pages: 10 - 10

29. Carbimazole/thiamazole

    Case report 19 January 2013 Pages: 11 - 11

30. Carbamazepine

    Case report 19 January 2013 Pages: 11 - 11

31. Cisplatin/paclitaxel

    Case report 19 January 2013 Pages: 12 - 12

32. Cetuximab

    Case report 19 January 2013 Pages: 12 - 12

33. Cefepime

    Case report 19 January 2013 Pages: 12 - 12

34. Clarithromycin

    Case report 19 January 2013 Pages: 12 - 12

35. Cyclophosphamide

    Case report 19 January 2013 Pages: 13 - 13

36. Clotiapine/droperidol

    Case report 19 January 2013 Pages: 13 - 13

37. Cyclophosphamide/fludarabine/rituximab

    Case report 19 January 2013 Pages: 13 - 13

38. Cyclophosphamide

    Case report 19 January 2013 Pages: 13 - 13

39. Diclofenac

    Case report 19 January 2013 Pages: 14 - 14

40. Dopamine receptor antagonists/promazine

    Case report 19 January 2013 Pages: 14 - 14

41. Danazol

    Case report 19 January 2013 Pages: 14 - 14

42. Efavirenz

    Case report 19 January 2013 Pages: 15 - 15

43. Drug-eluting stents

    Case report 19 January 2013 Pages: 15 - 15

44. Doxycycline

    Case report 19 January 2013 Pages: 15 - 15

45. Erlotinib

    Case report 19 January 2013 Pages: 16 - 16

46. Etanercept

    Case report 19 January 2013 Pages: 16 - 16

47. Enoxaparin sodium

    Case report 19 January 2013 Pages: 16 - 16

48. Enoxaparin sodium/heparin

    Case report 19 January 2013 Pages: 16 - 16

49. Etanercept/infliximab

    Case report 19 January 2013 Pages: 17 - 17

50. Etanercept

    Case report 19 January 2013 Pages: 17 - 17